Home » Topics » Regulatory » EMA

EMA
RSS

Jakavi recommended for approval in Europe for polycythemia vera

Jan. 26, 2015

CHMP issues positive opinion for Prevenar 13 for prevention of pneumococcal pneumonia

Jan. 23, 2015

APR-246 receives European orphan drug designation

Jan. 23, 2015

EMA accepts AstraZeneca's lesinurad MAA for gout

Jan. 22, 2015

UCB confirms regulatory filings for antiepileptic drug brivaracetam

Jan. 22, 2015

EMA grants positive opinion for orphan drug status for enadenotucirev

Jan. 14, 2015

EMA accepts alirocumab MAA for review

Jan. 12, 2015

Celgene receives positive CHMP opinion to extend Revlimid indication

Dec. 24, 2014

EMA committee recommends approval of dalbavancin

Dec. 24, 2014

Xiapex receives positive opinion by CHMP for Peyronie's disease

Dec. 23, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...